Antipsychotic Long-acting Injections (LAIs) were introduced in the 1960s to improve treatment adherence in schizophrenia. Subsequently, first-generation antipsychotic LAIs became widely used in many countries. Since the initial publication of Antipsychotic Long-acting Injections in 2010, new trial data have been published on long-acting injection (LAI) preparations of the drugs Risperidone, Paliperidone, and Olanzapine. Furthermore, a new LAI preparation of the drug Aripiprazole has recently been approved for clinical use ...

Antipsychotic Long-acting Injections 2016, Oxford University Press, Oxford

ISBN-13: 9780198729471

2nd Revised edition

Paperback

Select
Antipsychotic Long-acting Injections 2010, Oxford University Press, Oxford

ISBN-13: 9780199586042

Paperback

Select